• About
    • Team
    • Partnerships
  • Products
    • Alvesco
    • Feraheme
    • Makena
    • Tudorza
    • All products
  • Patient Assistance Program
  • Medical Affairs
    • Request a MSL
    • Medical Information
    • IME Grants
    • ISR
  • Development
  • News
  • Careers
  • Contact
  • About
    • Team
    • Partnerships
  • Products
    • Alvesco
    • Feraheme
    • Makena
    • Tudorza
    • All products
  • Patient Assistance Program
  • Medical Affairs
    • Request a MSL
    • Medical Information
    • IME Grants
    • ISR
  • Development
  • News
  • Careers
  • Contact

News release 2023

Covis Pharma Responds to Presiding Officer’s Report Summarizing FDA Advisory Committee Hearing

March 7, 2023

News release

  • Contact Us
  • 2023
  • 2022
  • 2021
  • 2020
  • 2018
  • 2017
  • 2015
  • 2013
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset